White House Reportedly Told FDA Head: Approve Vaccine Today Or Resign

Topline

White House chief of staff Mark Meadows told the head of the Food and Drug Administration on Friday to either sign off on Pfizer’s coronavirus vaccine by the end of the day or hand in his resignation, the Washington Post reported, another push by the White House to approve the vaccine as quickly as possible after a panel of scientists ruled it safe this week.

Key Facts

In a Friday morning call, Meadows urged FDA Commissioner Stephen Hahn to move up the drug’s emergency use authorization from Saturday to Friday, the Post and Axios reported, citing unnamed sources (the FDA told Forbes this characterization of the call is “untrue”).

President Donald Trump also excoriated the FDA Friday, calling the agency a “big, old, slow turtle” on Twitter and urging Hahn to “stop playing games and start saving lives.”

The FDA reportedly planned on issuing final approval for Pfizer’s vaccine on Saturday, just two days after an FDA advisory committee voted to endorse the drug, but the Post reported the agency could move this announcement to Friday.

The White House did not respond to a request for comment.

Crucial Quote

“The FDA was encouraged to continue working expeditiously on Pfizer-BioNTech’s EUA request,” Hahn said in a statement explaining his call with Meadows. “FDA is committed to issuing this authorization quickly.”

What To Watch For

The FDA is widely expected to grant emergency use authorization for Pfizer’s vaccine in the coming days, after it finishes up various regulatory and procedural steps. Millions of vaccine doses will be shipped across the country within 24 hours of the FDA’s final sign-off, the New York Times reported, and the first patients could get the vaccine by next week.

Key Background

The FDA’s Vaccine and Related Biological Products Advisory Committee, a group of doctors and public health experts, greenlit Pfizer’s vaccine on Thursday after hours of discussion. The committee deemed the vaccine safe and effective against Covid-19, based on promising data from clinical trials. Pfizer’s candidate will be the first vaccine to reach patients, though the FDA is considering another highly effective vaccine from Moderna next week.

Tangent

Trump has spent months pressuring the FDA to move Covid-19 vaccines through the approval process as quickly as possible, baselessly accusing the agency of somehow deliberately delaying vaccine trials. In contrast, experts like Dr. Anthony Fauci — who sits on the White House’s coronavirus task force — have worked to combat the perception that the approval process is rushed, warning people could distrust the final product as a result.

Further Reading

White House orders FDA chief to authorize Pfizer-BioNTech vaccine Friday or submit his resignation (Washington Post)

Vaccine Advisory Committee Endorses Pfizer Covid-19 Vaccine, Paves Way For FDA Authorization (Forbes)


Speak Your Mind

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get in Touch

350FansLike
100FollowersFollow
281FollowersFollow
150FollowersFollow

Recommend for You

Oh hi there 👋
It’s nice to meet you.

Subscribe and receive our weekly newsletter packed with awesome articles that really matters to you!

We don’t spam! Read our privacy policy for more info.

You might also like

Air Force Is Looking At Using Magnetic Fields To...

An F-16 Fighting Falcon from the 412th Test Wing’s...

Bill Gates Predicted the Pandemic. Here’s When He Thinks...

Much has been made of the fact that Bill Gates, in a 2015 Ted...

Joompay launches its bill-splitting payment app across Europe to...

Joompay, a startup with an iOS and Android app similar to Venmo and TransferWise,...

Presidential Debate: A Mute Button is Great. But it Doesn’t Solve...

It's certainly welcome news that the Commission on Presidential Debates is trying to avoid...